快驗保 MED 深 滬
已收盤 04-02 16:00:00 美东时间
10.36
+0.260
+2.57%
華盛通- 最 高10.36
- 今 開10.06
- 成交量 15.97万股
- 最 低 10.00
- 昨 收 10.10
- 總市值 1.14亿
- 52周最高 15.46
- 市盈率 靜 --
- 換手率 1.45%
- 52周最低 9.22
- 委 比 -69.14%
- 總股本 1099.13万
- 歷史最高 321.22
- 量 比 0.65
- 振 幅 3.56%
- 歷史最低 -17.07
- 每 手 1
- 風險率 1.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Medifast Agrees To Nominate Steamboat Capital Partners' Parsa Kiai, Jeff Rose As Independent Director Candidates
Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Directors has agreed to nominate Parsa Kiai and
03-20 20:34
Medifast adds Steamboat nominees to board slate to boost stockholder value at May 19, 2026 meeting
Medifast adds Steamboat nominees to board slate to boost stockholder value at May 19, 2026 meeting Medifast reached a cooperation agreement with Steamboat Capital, which said it beneficially owns above 5% of the company’s outstanding shares. Board nominations under the agreement include Parsa Kiai a
03-20 20:30
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Rhythm Pharmaceuticals says EMANATE trial misses goals, despite BMI reduction signals and continued pipeline development plans.
03-17 19:12
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
电话会总结 ｜ Medifast(MED)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Medifast业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第四季度营收7,510万美元，同比下降36.9%，主要受活跃教练数量减少40.6%影响。活跃教练数量降至约16,100人。 **盈利能力：** 毛利润5,210万美元，同比下降40.9%；毛利率69.4%，同比下降470个基点。运营亏损780万美元（占营收10.4%），而上年同期为运营利润70万美元（占营收0.6%）。 **净利润：** 净亏损1,810万美元，每股亏损1.65美元，而上年同期为净利润80万美元，每股收益0.07美元。扣除1,210万美
02-18 12:31
Medifast Q4 revenue falls 36.9% on fewer coaches
Medifast Q4 revenue falls 36.9% on fewer coaches Overview Health and wellness firm's Q4 revenue fell 36.9% yr/yr due to fewer active coaches Company reported Q4 net loss of $18.1 mln, impacted by tax provision charge Medifast reinstates annual guidance, focusing on metabolic health strategy Outlook
02-18 05:15
Medifast Q4 net income posts USD -18.1 million loss as revenue drops 36.9 percent to USD 75.1 million
Medifast Q4 net income posts USD -18.1 million loss as revenue drops 36.9 percent to USD 75.1 million Medifast Inc. reported full-year (FY) 2025 revenue of USD 385.79 million, with a net loss of USD 18.7 million, or USD 1.70 per diluted share. The net loss includes a tax provision charge related to
02-18 05:06
BRIEF-Medifast Q4 Revenue USD 75.096 Million
BRIEF-Medifast Q4 Revenue USD 75.096 Million Feb 17 (Reuters) - Medifast Q4 EPS USD -1.65. Q4 net income USD -18.119 million outlook Q1 revenue USD 65-80 million outlook Q1 EPS USD -0.7 to -0.15
02-18 05:05
Earnings Scheduled For February 17, 2026
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likel...
02-17 19:11
What to Expect from Medifast's Earnings
Medifast (NYSE:MED) is gearing up to announce its quarterly earnings on Tuesday...
02-17 04:02
